Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection

Tuberculosis (TB) is currently one of the leading causes of death due to infective agents, and the growing rate of multidrug-resistant tuberculosis (MDR TB) cases poses an emergent public health threat. Fluoroquinolones are commonly used in the treatment of both MDR TB and drug-sensitive tuberculosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pais, João Pedro, Policarpo, Margarida, Pires, David, Francisco, Ana Paula, Madureira, Ana Margarida, Testa, Bernard, Anes, Elsa, Constantino, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609866/
https://www.ncbi.nlm.nih.gov/pubmed/36297325
http://dx.doi.org/10.3390/ph15101213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609866/
https://www.ncbi.nlm.nih.gov/pubmed/36297325
http://dx.doi.org/10.3390/ph15101213

Ejemplares similares